unknown
Stage
2022
Founded
2
Investors
About
Cellular Intelligence builds computational and cell-therapy platforms to design biological systems and develop next-generation cell therapies. The company works with leading academic scientists and has acquired programs such as STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease.
Explore Cellular Intelligence's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.